Fredun Pharmaceuticals Profit & Loss Annual

BSE: 539730 | NSE: - | ISIN: INE194R01017 | Sector: Biotechnology & Drugs

708.00 +34.30 (5.09%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	349.07	274.34	221.74	131.55
Total Revenue	349.07	274.34	221.74	131.55
Costof Revenue Total	274.94	217.36	183.38	106.40
Gross Profit	74.13	56.98	38.36	25.15
Selling/ General/ Admin Expenses Total	12.50	15.45	13.82	10.83
Research Development	0.00	-	-	-
Depreciation/ Amortization	3.80	2.81	2.16	2.00
Unusual Expense( Income)	0.00	-	0.00	1.16
Other Operating Expenses Total	22.73	13.39	10.71	4.99
Total Operating Expense	313.97	249.01	210.06	125.39
Operating Income	35.10	25.33	11.67	6.16
Interest Inc( Exp) Net- Non- Op Total	-136.50	-67.91	-31.69	-38.64
Net Income Before Taxes	21.45	17.51	8.60	3.21
Provisionfor Income Taxes	5.83	6.70	2.26	1.19
Net Income After Taxes	15.62	10.81	6.34	2.01
Net Income Before Extra Items	15.62	10.81	6.34	2.01
Net Income	15.62	10.81	6.34	2.01
Income Availableto Com Excl Extra Ord	15.62	10.81	6.34	2.01
Income Availableto Com Incl Extra Ord	15.62	10.81	6.34	2.01
Diluted Net Income	15.62	10.81	6.34	2.01
Diluted Weighted Average Shares	0.47	0.47	0.45	0.40
Diluted EPS Excluding Extra Ord Items	33.32	22.93	14.23	5.05
DPS- Common Stock Primary Issue	0.70	0.70	0.70	0.70
Diluted Normalized EPS	33.32	23.05	14.23	6.88
Gain( Loss)on Saleof Assets	-	-0.90	-	-
Other Net	-	-0.94	0.09	0.91